Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #829 on Bristol Myers Squibb (BMY)
DewDiligence
06/24/19 9:27 AM
#855 RE: DewDiligence #829
Once the FTC accepts the consent order and the other customary closing conditions are satisfied, Bristol-Myers Squibb intends to close the Celgene transaction at the earliest possible date, which it currently expects to be at the end of 2019 or the beginning of 2020.